Fresenius Kabi, a company based in Germany, landed FDA clearance for its Aurora Xi Plasmapheresis System. The device is designed to improve the process of blood plasma collection, particularly speeding up the filtration process and allowing for more donors to donate in the same amount of time.
The company developed its own proprietary filtration technology that powers the Aurora Xi, which it hopes will result in more plasma donations and improved economics for the clinics doing this work.
“The Aurora Xi system features a proprietary filtration-separation method that enables the faster collection of Source Plasma. The system helps to improve plasma center efficiency and the overall experience for operators and donors,” said Dean Gregory, president, medical devices, Fresenius Kabi USA, in a statement. “Faster collection times mean more throughput for our customers, helping maximize the volumes of plasma they collect while assuring a good experience for plasma donors.”
Via: Fresenius Kabi…